Alzamend Neuro, Inc. (ALZN)
2.00
+0.12
(+6.38%)
USD |
NASDAQ |
Mar 04, 16:00
2.00
0.00 (0.00%)
After-Hours: 20:00
Alzamend Neuro Shareholders Equity (Quarterly) : 4.374M for Oct. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Allogene Therapeutics, Inc. | 315.33M |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Agenus, Inc. | -274.14M |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Savara, Inc. | 94.39M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.092M |
| Total Liabilities (Quarterly) | 0.7175M |
| Current Ratio | 6.580 |